Cynthia G. Whitney

38.2k total citations · 11 hit papers
256 papers, 26.0k citations indexed

About

Cynthia G. Whitney is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Cynthia G. Whitney has authored 256 papers receiving a total of 26.0k indexed citations (citations by other indexed papers that have themselves been cited), including 212 papers in Epidemiology, 66 papers in Microbiology and 40 papers in Infectious Diseases. Recurrent topics in Cynthia G. Whitney's work include Pneumonia and Respiratory Infections (200 papers), Respiratory viral infections research (132 papers) and Pneumocystis jirovecii pneumonia detection and treatment (71 papers). Cynthia G. Whitney is often cited by papers focused on Pneumonia and Respiratory Infections (200 papers), Respiratory viral infections research (132 papers) and Pneumocystis jirovecii pneumonia detection and treatment (71 papers). Cynthia G. Whitney collaborates with scholars based in United States, United Kingdom and South Africa. Cynthia G. Whitney's co-authors include Daniel M. Musher, Monica M. Farley, Scott F. Dowell, Nancy M. Bennett, Antonio Anzueto, Nathan C. Dean, Lee H. Harrison, John G. Bartlett, Lionel A. Mandell and Thomas M. File and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Cynthia G. Whitney

252 papers receiving 25.0k citations

Hit Papers

Infectious Diseases Society of America/American Thoracic ... 2000 2026 2008 2017 2007 2019 2003 2009 2003 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
    2007 4.4k citations Antonio Anzueto, Nathan C. Dean et al. profile →
  2. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
    2019 2.0k citations Joshua P. Metlay, Grant Waterer et al. American Journal of Respiratory and Critical Care Medicine profile →
  3. Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine
    2003 1.7k citations Cynthia G. Whitney, Monica M. Farley et al. profile →
  4. Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
    2009 1.0k citations Tamara Pilishvili, Monica M. Farley et al. The Journal of Infectious Diseases profile →
  5. Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent Adults
    2003 729 citations Daniel M. Musher, Cynthia G. Whitney et al. profile →
  6. Increasing Prevalence of Multidrug-ResistantStreptococcus pneumoniaein the United States
    2000 691 citations Cynthia G. Whitney, Monica M. Farley et al. profile →
  7. Effect of Introduction of the Pneumococcal Conjugate Vaccine on Drug-Resistant Streptococcus pneumoniae
    2006 653 citations Ruth Lynfield, Allen S. Craig et al. profile →
  8. Bacterial Meningitis in the United States, 1998–2007
    2011 632 citations Cynthia G. Whitney, Elizabeth R. Zell et al. profile →
  9. Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices.
    2014 549 citations Nancy M. Bennett, Ryan Gierke et al. PubMed profile →
  10. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study
    2006 503 citations Cynthia G. Whitney, Monica M. Farley et al. The Lancet profile →
  11. U.S. Hospitalizations for Pneumonia after a Decade of Pneumococcal Vaccination
    2013 371 citations Marie R. Griffin, Cynthia G. Whitney et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cynthia G. Whitney United States 68 21.2k 6.8k 3.7k 2.5k 2.1k 256 26.0k
Daniel M. Musher United States 75 17.3k 0.8× 3.2k 0.5× 6.9k 1.8× 2.9k 1.2× 2.4k 1.1× 340 26.9k
Keith P. Klugman United States 79 18.5k 0.9× 6.6k 1.0× 4.2k 1.1× 2.7k 1.1× 726 0.3× 395 25.0k
Monica M. Farley United States 79 18.8k 0.9× 6.8k 1.0× 9.4k 2.5× 7.2k 2.9× 731 0.3× 235 28.0k
Lee H. Harrison United States 85 19.7k 0.9× 8.7k 1.3× 10.0k 2.7× 6.0k 2.4× 857 0.4× 389 29.9k
Scott F. Dowell United States 56 11.0k 0.5× 1.6k 0.2× 4.6k 1.2× 1.8k 0.7× 1.6k 0.8× 139 18.0k
William Schaffner United States 73 11.7k 0.6× 3.9k 0.6× 5.1k 1.4× 3.4k 1.4× 714 0.3× 453 21.1k
Ron Dagan Israel 77 15.6k 0.7× 7.1k 1.0× 3.3k 0.9× 3.5k 1.4× 724 0.3× 597 22.2k
Ruth Lynfield United States 59 10.8k 0.5× 3.3k 0.5× 5.8k 1.5× 5.0k 2.0× 564 0.3× 274 19.2k
Sheldon L. Kaplan United States 69 11.1k 0.5× 5.2k 0.8× 11.3k 3.0× 7.5k 3.0× 919 0.4× 361 26.0k
Thomas M. File United States 51 15.1k 0.7× 1.3k 0.2× 3.9k 1.1× 1.5k 0.6× 2.6k 1.2× 266 21.4k

Countries citing papers authored by Cynthia G. Whitney

Since Specialization
Citations

This map shows the geographic impact of Cynthia G. Whitney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cynthia G. Whitney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cynthia G. Whitney more than expected).

Fields of papers citing papers by Cynthia G. Whitney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cynthia G. Whitney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cynthia G. Whitney. The network helps show where Cynthia G. Whitney may publish in the future.

Co-authorship network of co-authors of Cynthia G. Whitney

This figure shows the co-authorship network connecting the top 25 collaborators of Cynthia G. Whitney. A scholar is included among the top collaborators of Cynthia G. Whitney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cynthia G. Whitney. Cynthia G. Whitney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kahn, Rebecca, Benild Moiane, Fernanda C. Lessa, et al.. (2025). Nasopharyngeal carriage of Streptococcus pneumoniae among children and their household members in southern Mozambique five years after PCV10 introduction. Vaccine. 47. 126691–126691. 1 indexed citations
3.
King, Laura, Kristin L. Andrejko, Miwako Kobayashi, et al.. (2025). Pneumococcal Serotype Distribution and Coverage of Existing and Pipeline Pneumococcal Vaccines. The Journal of Infectious Diseases. 232(4). e609–e620.
4.
Nisar, Muhammad Imran, Sheraz Ahmed, Furqan Kabir, et al.. (2022). Pneumococcal Carriage in Infants Post-PCV10 Introduction in Pakistan: Results from Serial Cross-Sectional Surveys. Vaccines. 10(6). 971–971. 2 indexed citations
5.
Madewell, Zachary J., et al.. (2022). Prioritising health-care strategies to reduce childhood mortality, insights from Child Health and Mortality Prevention Surveillance (CHAMPS): a longitudinal study. Oxford University Research Archive (ORA) (University of Oxford). 2 indexed citations
6.
Cissé, Assana, Jennifer Milucky, Jessica L. Waller, et al.. (2021). Comparison of performance between Fast Track Diagnostics Respiratory Kit and the CDC global reference laboratory for influenza rRT‐PCR panel for detection of influenza A and influenza B. Influenza and Other Respiratory Viruses. 15(3). 381–388. 4 indexed citations
7.
Metlay, Joshua P., Grant Waterer, Ann C. Long, et al.. (2019). Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. American Journal of Respiratory and Critical Care Medicine. 200(7). e45–e67. 2029 indexed citations breakdown →
8.
Ouedraogo-Traoré, Rasmata, Isaïe Médah, Lassana Sangaré, et al.. (2017). Early impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis—Burkina Faso, 2014–2015. Journal of Infection. 76(3). 270–279. 23 indexed citations
9.
Metcalf, Benjamin J., Robert E. Gertz, Rebecca A. Gladstone, et al.. (2015). Strain features and distributions in pneumococci from children with invasive disease before and after 13-valent conjugate vaccine implementation in the USA. Clinical Microbiology and Infection. 22(1). 60.e9–60.e29. 144 indexed citations
10.
Saha, Samir K., Belal Hossain, Mohammad Shahidul Islam, et al.. (2015). Epidemiology of Invasive Pneumococcal Disease in Bangladeshi Children Before Introduction of Pneumococcal Conjugate Vaccine. The Pediatric Infectious Disease Journal. 35(6). 655–661. 25 indexed citations
11.
Mollendorf, Claire von, Cheryl Cohen, Linda de Gouveia, et al.. (2014). Risk Factors for Invasive Pneumococcal Disease Among Children Less Than 5 Years of Age in a High HIV Prevalence Setting, South Africa, 2010 to 2012. The Pediatric Infectious Disease Journal. 34(1). 27–34. 14 indexed citations
12.
Whitney, Cynthia G., Fangjun Zhou, James A. Singleton, & Anne Schuchat. (2014). Benefits from immunization during the vaccines for children program era - United States, 1994-2013.. PubMed. 63(16). 352–5. 183 indexed citations
13.
Modak, Joyanta K., Hassan M. Al‐Emran, Mohammad Shahidul Islam, et al.. (2014). Detection of co-colonization with Streptococcus pneumoniae by algorithmic use of conventional and molecular methods. Vaccine. 33(5). 713–718. 17 indexed citations
14.
Fleming-Dutra, Katherine E., Laura Conklin, Jennifer D. Loo, et al.. (2013). Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Vaccine-type Nasopharyngeal Carriage. The Pediatric Infectious Disease Journal. 33(Supplement 2). S152–S160. 77 indexed citations
15.
Bennett, Nancy M., et al.. (2013). Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6–18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morbidity and Mortality Weekly Report. 62(25). 521–524. 123 indexed citations
16.
Nuorti, J. Pekka & Cynthia G. Whitney. (2010). Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23).. MMWR Morbidity and Mortality Weekly Report. 59(34). 1102–1106. 294 indexed citations
17.
O’Brien, Katherine L., Orin S. Levine, Cynthia G. Whitney, et al.. (2006). Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study.(Clinical report). The Lancet. 368(9546). 61 indexed citations
18.
Hicks, Lauri A., Charles E. Rose, Barry S. Fields, et al.. (2006). Increased rainfall is associated with increased risk for legionellosis. Epidemiology and Infection. 135(5). 811–817. 83 indexed citations
19.
Stephens, David S., Susu M. Zughaier, Cynthia G. Whitney, et al.. (2005). Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment. The Lancet. 365(9462). 855–863. 133 indexed citations
20.
Ridzon, Renée, Cynthia G. Whitney, Matthew T. McKenna, et al.. (1998). Risk Factors for Rifampin Mono-resistant Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 157(6). 1881–1884. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel M. Musher Breakdown of academic impact, for papers by Keith P. Klugman Breakdown of academic impact, for papers by Monica M. Farley Breakdown of academic impact, for papers by Lee H. Harrison Breakdown of academic impact, for papers by Scott F. Dowell Breakdown of academic impact, for papers by William Schaffner Breakdown of academic impact, for papers by Ron Dagan Breakdown of academic impact, for papers by Ruth Lynfield Breakdown of academic impact, for papers by Sheldon L. Kaplan Breakdown of academic impact, for papers by Thomas M. File
Rankless by CCL
2026